Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Garlits

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Bioanalysis|June 19, 2019
Mitigating target interference in bridging immunogenicity assay with target-blocking reagents and mild basic pHJihua Chen, John Garlits, Gangadhar Dhulipala, et al.
Bioanalysis|May 11, 2017
Bridging immunogenicity assays for IgG4 therapeutics: mitigating interference from Fc-Fc interactionsMichael A Partridge, Uma Vijayam, Elif Kabuloglu Karayusuf, et al.
The AAPS Journal|April 4, 2023
Statistical Approaches for Establishing Appropriate Immunogenicity Assay Cut Points: Impact of Sample Distribution, Sample Size, and Outlier RemovalJohn Garlits, Sean McAfee, Jessica-Ann Taylor, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Bioanalysis|June 19, 2019
Mitigating target interference in bridging immunogenicity assay with target-blocking reagents and mild basic pHJihua Chen, John Garlits, Gangadhar Dhulipala, et al.
Bioanalysis|May 11, 2017
Bridging immunogenicity assays for IgG4 therapeutics: mitigating interference from Fc-Fc interactionsMichael A Partridge, Uma Vijayam, Elif Kabuloglu Karayusuf, et al.
The AAPS Journal|April 4, 2023
Statistical Approaches for Establishing Appropriate Immunogenicity Assay Cut Points: Impact of Sample Distribution, Sample Size, and Outlier RemovalJohn Garlits, Sean McAfee, Jessica-Ann Taylor, et al.
Pageof 1